Category
Benzydamine
CAS Number
2215-63-6
Molecular Formula
C₁₄H₁₂N₂O
Molecular Weight
224.26 g/mol
Synonym

1-Benzyl-3-hydroxyindazole ; 1,2-Dihydro-1-(phenylmethyl)-3H-indazol-3-one; 1-Benzyl-1,2-dihydro-3H-indazol-3-one; 1-Benzyl-1H-indazol-3-ol; 1-Benzyl-1H-indazol-3-ol; 3-Hydroxy-1-benzyl-1H-indazole; 1-Benzyl-3-indazolone;

 

Keywords
High-Quality Pharmaceutical Reference Standards
Intermediates
Aromatics
Impurities Manufacturer in India
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Benzydamine EP Impurity C (CAS No. 2215-63-6) is a pharmaceutical impurity reference standard with a molecular formula of C₁₄H₁₂N₂O and a molecular weight of 224.26 g/mol. It is suitable for pharmaceutical research, analytical method development, impurity profiling, related-substances analysis, and API quality-control applications.

Manasa Life Sciences supplies Benzydamine EP Impurity C as an analytical reference material for impurity identification, HPLC method validation, LC-MS analysis, ¹H NMR and ¹³C NMR characterization, FTIR spectroscopy, and stability-indicating analytical studies. Product-specific documentation, including Certificate of Analysis (COA), SDS/MSDS, HPLC chromatograms, spectral characterization reports, and batch traceability records, may be provided subject to availability. The product supports pharmaceutical manufacturers, quality-control laboratories, contract research organizations (CROs), and analytical research institutions across India, the UAE, GCC countries, Asia, Europe, and Africa, with testing activities aligned to applicable ICH, USP, EP, EMA, and WHO regulatory guidelines.